NZ185772A - A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated - Google Patents

A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated

Info

Publication number
NZ185772A
NZ185772A NZ185772A NZ18577277A NZ185772A NZ 185772 A NZ185772 A NZ 185772A NZ 185772 A NZ185772 A NZ 185772A NZ 18577277 A NZ18577277 A NZ 18577277A NZ 185772 A NZ185772 A NZ 185772A
Authority
NZ
New Zealand
Prior art keywords
complex
treated
coated
pharmaceutical composition
ion exchange
Prior art date
Application number
NZ185772A
Other languages
English (en)
Inventor
Y Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NZ185772A publication Critical patent/NZ185772A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ185772A 1976-11-26 1977-11-24 A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated NZ185772A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (1)

Publication Number Publication Date
NZ185772A true NZ185772A (en) 1978-12-18

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185772A NZ185772A (en) 1976-11-26 1977-11-24 A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated

Country Status (21)

Country Link
JP (1) JPS609697B2 (xx)
AR (1) AR218047A1 (xx)
AT (1) AT359197B (xx)
AU (1) AU511080B2 (xx)
BE (1) BE861141A (xx)
CA (1) CA1086226A (xx)
CH (1) CH639560A5 (xx)
DE (1) DE2752728C2 (xx)
DK (1) DK150534C (xx)
FI (1) FI65910C (xx)
FR (1) FR2373288A1 (xx)
GB (1) GB1544761A (xx)
GR (1) GR61724B (xx)
IE (1) IE45998B1 (xx)
IL (1) IL53462A (xx)
LU (1) LU78584A1 (xx)
NL (1) NL182283C (xx)
NO (1) NO147626C (xx)
NZ (1) NZ185772A (xx)
PT (1) PT67323B (xx)
SE (1) SE426781B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
BR112020007061A2 (pt) * 2017-10-09 2020-10-06 Rhodes Pharmaceuticals L.P. composições resinadas farmacêuticas e métodos para a sua fabricação e uso
US11801956B2 (en) * 2019-05-23 2023-10-31 G.D Societa' Per Azioni Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (xx) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
DK150534B (da) 1987-03-23
NO774051L (no) 1978-05-29
DE2752728A1 (de) 1978-06-01
SE7713370L (sv) 1978-05-27
IE45998L (en) 1978-05-26
NO147626B (no) 1983-02-07
AT359197B (de) 1980-10-27
IL53462A0 (en) 1978-01-31
JPS5369822A (en) 1978-06-21
DE2752728C2 (de) 1985-08-01
NL182283C (nl) 1988-02-16
LU78584A1 (xx) 1978-04-20
DK523277A (da) 1978-05-27
FI65910C (fi) 1984-08-10
SE426781B (sv) 1983-02-14
DK150534C (da) 1987-10-12
IE45998B1 (en) 1983-01-26
PT67323B (en) 1979-04-24
JPS609697B2 (ja) 1985-03-12
CA1086226A (en) 1980-09-23
PT67323A (en) 1977-12-01
FI65910B (fi) 1984-04-30
IL53462A (en) 1980-12-31
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
AU511080B2 (en) 1980-07-24
NL182283B (nl) 1987-09-16
FR2373288A1 (fr) 1978-07-07
GB1544761A (en) 1979-04-25
AR218047A1 (es) 1980-05-15
NL7712996A (nl) 1978-05-30
FI773568A (fi) 1978-05-27
NO147626C (no) 1983-05-25
CH639560A5 (en) 1983-11-30
BE861141A (fr) 1978-03-16
FR2373288B1 (xx) 1980-06-13
AU3098677A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
JPS5270993A (en) Liquid composite and use as preserving agent
JPS5334730A (en) Complex compound* preparation thereof and antistatic agent containing same
HU175439B (hu) Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta
JPS51143837A (en) Battery and cathodeeadjusting agent
NZ185772A (en) A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated
CS188140B2 (en) Herbicide agent and method of preparation of the active agent
JPS5214693A (en) Sulfurrcontaining unsaturated resin and highly reactive sulfurrcontaining coating agent
YU40456B (en) Device for manufacturing self-sealing coating and insulanig foils
NZ179948A (en) A pharmaceutical composition comprising powdered amoxycillin coated with a dispersing agent veterinary methods
JPS5359724A (en) Polymeric coloring agent and process for manufacture thereof
EG12472A (en) Process and device for spraying liquids
ZA767216B (en) Improved method of manufacturing ion exchange types of resins and the use of same
JPS5320433A (en) Pharmaceutical composition and application
JPS5310684A (en) Aqueous baseesoluble solid resin and coating composition containing same
JPS5379010A (en) Treating agent for metabolic disorder and use thereof
JPS52125800A (en) Impregnating agent for electric devices and the use thereof
JPS5235223A (en) Powdered coating agent and production thereof
JPS5238541A (en) Powdered coating agent and production thereof
JPS5238542A (en) Powdered coating agent and production thereof
GR60264B (en) Stable solutions and processes for their preparation
JPS5217431A (en) Phenoxyalkylamides and tickcide containing the same
JPS52112631A (en) Powdered coating agent
JPS5333230A (en) Powdered coating agent excellent in stability for storage and production thereof
CS189030B2 (en) Fundicide means and method of making the active agent
JPS5238543A (en) Powdered coating agent and production thereof